We also included an HLA-A*01/HLA-A*24 bearing BRAFV600E mutated colon carcinoma cell line (HT29) with earlier confirmed HLA (72–74) and BRAFV600E protein (75, 76) expression in our analysis. This evidence concerns the gene HLA-A and colon carcinoma.